Denali Therapeutics (DNLI) Insider Trades, Congress & Funds

Smart money at a glance

Filings to Nov 14, 2026

Net selling: insiders sold $364K and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: -$364K net
CongressSTOCK Act, 180 days: None
Big funds13F, quarter ended Mar 31, 2026: 0 added, 1 cut
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about DNLI filings

Are insiders buying or selling Denali Therapeutics Inc (DNLI) stock?

Net selling: insiders sold $364K and bought $0 of DNLI stock on the open market in the 90 days to Nov 14, 2026, according to SEC Form 4 filings. $327K of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Thornberry, Nancy (Director), who sold $262K. The latest filing was on Sep 9, 2026.

Which members of Congress have traded DNLI recently?

None. No member of Congress disclosed a DNLI trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this DNLI smart-money data?

This summary uses filings available on Nov 14, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

Smart money on DNLI

Lean short1 source:
- Insiders

Top traders
No tracked positions at the last update
Insiders
Lean short3 sales · $364K
2 of 3 on scheduled plans. Form 4 filings.
Congress
No recent politician filings found
Funds
No recent fund filings found
Influencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about DNLI filings

Are insiders buying or selling Denali Therapeutics Inc (DNLI) stock?

Which members of Congress have traded DNLI recently?

None. No member of Congress disclosed a DNLI trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this DNLI smart-money data?

Insiders

What insiders are doing

4 trades · 6 mo

Sold$435K

Sells (3)

CP
Chin Peter Scott
Chief Medical Officer · Cluster · Sep 9
$37K
sold
TN
Thornberry Nancy
Dir · Cluster · Sep 4
$262K
sold
SA
Schuth Alexander O.
COFO and Secretary · Cluster · Sep 3
$65K
sold

1 more trades

Pro opens all of them for $16.50/month, paid yearly.

Unlock all 1 trades

Unlock everything for $29/month

Unlock for $29/month

Reported Nov 3, 2026

Earnings came in 79.3% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Nov 3, 2026

Period ending

Sep 30, 2026

Earnings per share

-$0.66-79.32% miss

-$0.37 expected

Revenue

$17.8M

SEC filing

EPS: Yahoo Finance

Next report

What the street expects next

Estimates as of Nov 10, 2026

EPS expected

-$0.61

-$0.69 to -$0.50

Revenue expected

$31.4M

16 analysts

Last 30 days

0up1down

Analysts cutting estimates

Estimate drift

+0.01

Change in 30 days

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Nov 3, 2026	-$0.66est. -$0.37	-79.32%miss	$17.8MSEC filing	No year-ago quarter
Jun 30, 2026Reported Aug 6, 2026	-$0.68est. -$0.47	-45.48%miss	$3.6MSEC filing	No year-ago quarter
Mar 31, 2026Reported May 7, 2026	-$0.69est. -$0.71	+2.32%beat	$0.00Yahoo Finance	No year-ago quarter
Dec 31, 2025Reported Feb 26, 2026	-$0.73est. -$0.75	+2.52%beat	$0.00Yahoo Finance	No year-ago quarter
Sep 30, 2025Reported Nov 6, 2025	-$0.74est. -$0.76	+2.63%beat	Not on file	Not on file
Jun 30, 2025Reported Aug 11, 2025	-$0.72est. -$0.74	+2.70%beat	$0.00SEC filing	No year-ago quarter
Mar 31, 2025Reported May 6, 2025	-$0.78est. -$0.70	-11.43%miss	Not on file	Not on file
Dec 31, 2024Reported Feb 27, 2025	-$0.67est. -$0.85	+20.79%beat	$0.00 · FYSEC filing	No year-ago quarter

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $19.39
High: $19.60
Low: $18.80
Prev close: $19.73
52-wk high: $27.30
52-wk low: $15.34
Mkt cap: $3.03B
ROE: -33.9%
Beta: 1.08
P/S: 141.6x
P/B: 3.4x
Profit margin: +0.0%
Op margin: -2481.0%

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $3.0B

Valuation

P/S141.61
P/B3.41

Quality

Operating margin-2481.0%
ROE-33.9%
ROA-28.7%

Growth

Beta1.08

Technicals

Price structure

This stock is under pressure.

Trend

Under pressure

35 / 100

RSI 14

54balanced

20D volatility

51%annualized

52-week range

$18.89

$15.34$27.30

20D support

$17.33recent floor

20D resistance

$22.19recent ceiling

Returns

5D -4.2%20D +3.0%60D -26.5%

Price vs moving averages

SMA20 -1.5%SMA50 -4.9%SMA200 -11.1%

Volume pace

0.82xvs prior 20D

Quarter / reported

Earnings per share

Beat or miss

Revenue / income

Revenue vs last year

Sep 30, 2026Nov 3, 2026

-$0.66est. -$0.37

-79.32%

$17.8MSEC filing

No year-ago quarter

Jun 30, 2026Aug 6, 2026

-$0.68est. -$0.47

-45.48%

$3.6MSEC filing

No year-ago quarter

Mar 31, 2026May 7, 2026

-$0.69est. -$0.71

+2.32%

$0.00Yahoo Finance

No year-ago quarter

Dec 31, 2025Feb 26, 2026

-$0.73est. -$0.75

+2.52%

$0.00Yahoo Finance

No year-ago quarter

Sep 30, 2025Nov 6, 2025

-$0.74est. -$0.76

+2.63%

Not on file

Jun 30, 2025Aug 11, 2025

-$0.72est. -$0.74

+2.70%

$0.00SEC filing

No year-ago quarter

Mar 31, 2025May 6, 2025

-$0.78est. -$0.70

-11.43%

Not on file

Dec 31, 2024Feb 27, 2025

-$0.67est. -$0.85

+20.79%

$0.00 · FYSEC filing

No year-ago quarter

Denali Therapeutics Inc

Smart money at a glance

What do analysts expect?

Questions about DNLI filings

Smart money on DNLI

Questions about DNLI filings

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 79.3% below what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Denali Therapeutics Inc

Smart money at a glance

What do analysts expect?

Questions about DNLI filings

Smart money on DNLI

Questions about DNLI filings

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 79.3% below what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Denali Therapeutics Inc

Overview

Questions about DNLI filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Denali Therapeutics Inc

Overview

Questions about DNLI filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.